Skip to content

Effect of Smoking Cessation on Glycemic Control in Type 2 Diabetics

Effect of Smoking Cessation on Glycemic Control in Patients with Type 2 Diabetes

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06687213
Enrollment
178
Registered
2024-11-13
Start date
2024-11-30
Completion date
2025-12-31
Last updated
2024-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Brief summary

The goal of this observational study is to learn about the long-term effects of smoking cessation on glycemic control in type 2 diabetic patients The main question it aims to answer is: Does smoking cessation lower HbA1c in type 2 diabetics on long term ? The participants will be counseled to cessate smoking and will be followed for 6 months and compared to control who will not cessate smoking .

Detailed description

Smoking and diabetes are both major public health issues specially in our community. They act synergistically on morbidity and mortality. Diabetic smokers have much higher rates of micro and macrovascular complications. \[Carole Clair et al., 2020\] Approximately 1.3 billion people worldwide use tobacco, most commonly in the form of tobacco smoking, and more than 7 million people die every year as a result of smoking related conditions \[Magdalena Walicka et al.,2022\] Exposure to cigarette smoke is associated with vascular damage, endothelial dysfunction, and activation of oxidative stress, inflammatory pathways, coagulation, and fibrinolysis A similar mechanism of endothelial dysfunction is described for people with diabetes. It is therefore not surprising that smoking enhances the combined harmful effects of elevated blood glucose levels, accelerating vascular damage in diabetic patients who smoke The prevalence of current smoking was 45.5% in male patients with type 2 diabetes. The levels of fasting blood glucose and HbA1c increased with number of cigarettes smoked per day compared with non-smokers Smoking and its cessation showed dose- and time-dependent relationship with glycemic control and insulin resistance in patients with type 2 diabetes mellitus. These findings may highlight the importance of smoking cessation in the clinical management of diabetes mellitus. the effect of smoking and its cessation on glycemic control in diabetic patients has not been fully examined yet. There is lack of evidence regarding interventions for smoking cessation among individuals with diabetes

Interventions

Case group will be counseled to cessate smoking and will be followed up with HbA1c

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
35 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

\- Moderate Somking index Having been diagnosed with a type 2 diabetes Being ≥ 35 years old HbA1c \> 7

Exclusion criteria

Type 1 diabetes Drug induced Diabetes mellitus Type 2 diabetes on insulin treatment

Design outcomes

Primary

MeasureTime frame
Glycemic control after smoking cessation6 months

Countries

Egypt

Contacts

Primary ContactAlhasnaa M Rawy, Bachelor of medicine & surgery
alhsnaa.16266104@med.aun.edu.eg+2001023801711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026